Cryptocurrency Analysis and News Portal
There is consensus in the market that policymakers would provide unlimited support to asset prices if the situation worsens, leading to lockdowns. However, that would push governments and central banks in a tough spot. With inflation already running hotter than expected globally, lockdowns and more stimulus could lead to stagflation,
Read More
The potential efficacy in the approved Pfizer-BioNTech and Moderna vaccines is spurring a delay in second dose administration by some nations, especially those with limited supplies of the jabs.A new research study released by the United States Centers for Disease Control and Prevention (CDC) has revealed that the COVID-19 vaccines
Read More
This morning, news broke that Cambridge, Massachusetts-based biotech firm Moderna, had reached 94.5% efficiency in preventing the onset
Read More
The Moderna vaccine trial involved about 30,000 participants and the interim analysis for the vaccine was based on 95 infections among the trial participantsThe stock of an American biotechnology company that focuses on drug discovery, and drug development Moderna Inc (NASDAQ: MRNA) is soaring in today’s pre-market following reports that
Read More
Bitcoin was trading higher ahead of the New York opening bell Monday but risked shedding its intraday gains
Read More
Moderna CEO Stéphane Bancel cautioned that the drop in infection rates could prolong data analysis to December.The possibility of delayed vaccine distribution until the year’s end could hinder the momentum of the S&P 500.In addition to vaccine uncertainty, Anthony Fauci and the IATA are cautioning against other potential pandemic-related issues.Anthony
Read More
Moderna COVID-19 vaccine candidate dubbed mRNA-1273 has entered its late-stage trials. The company noted that as of Wednesday, September 16, 2020, about 25,296 participants have been enrolled.The CEO of biotechnology company Moderna Inc (NASDAQ: MRNA) Stephane Bancel has disclosed the company will know whether its COVID-19 vaccine candidate will be
Read More
Moderna (MRNA) stock price is rising. The rally is fueled by the company’s announcement that its COVID-19 vaccine candidate produced neutralizing antibodies in all 45 participants.Moderna Inc (NASDAQ: MRNA) stock rose by 15.88% to $92.72 to retest the previous ATH. Investors in the company had something concrete to hold on
Read More